Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Hydrogenated Castor Oil

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1ARTHROTEC

    02 2DICLOFENAC SODIUM AND MISOPROSTOL

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    ACTAVIS LABS FL INC

    DICLOFENAC SODIUM; MISOPROSTOL

    arrow
    2024 ACI Convention
    Not Confirmed
    ACTAVIS LABS FL INC
    Ireland
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DICLOFENAC SODIUM; MISOPROSTOL

    Drug : DICLOFENAC SODIUM AND MISOPROSTOL

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 201089

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    EXELA HOLDINGS

    DICLOFENAC SODIUM; MISOPROSTOL

    arrow
    2024 ACI Convention
    Not Confirmed
    EXELA HOLDINGS
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DICLOFENAC SODIUM; MISOPROSTOL

    Drug : DICLOFENAC SODIUM AND MISOPROSTOL

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 200540

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    PFIZER

    DICLOFENAC SODIUM; MISOPROSTOL

    arrow
    2024 ACI Convention
    Not Confirmed
    PFIZER
    U.S.A
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DICLOFENAC SODIUM; MISOPROSTOL

    Drug : ARTHROTEC

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Application Number : 20607

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF